InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,464.62
(
-0.16%
)
US TECH 100
19,230.00
(
-0.15%
)
Dow Jones
39,150.33
(
0.04%
)
Brent Oil
84.39
(
0.00%
)
Bitcoin
64,041.70
(
-0.07%
)
Post# of 413
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

lefty18

Send PM Follow Ignore
Followers 43
Posts 3041
Boards Moderated 1
Alias Born 08/09/2006

lefty18

Re: rumorman2006 post# 3

Tuesday, 08/15/2006 12:46:10 PM

Tuesday, August 15, 2006 12:46:10 PM

Post# of 413
I'll have to do more research on the status of their trials before I have an idea about that. They have more phase III trials on bicifadine on the way or in process. If they have success in one of those, it will rocket up quickly. Plus Indiplon still has a chance to be approved, which would bring in a constant stream of revenues.




Only the beginning.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up